Ingrid Hedenfalk

Universitetslektor, Docent, Dr Med Vet
Fler filtreringsmöjligheter
  1. 2019
  2. Afadin cooperates with Claudin-2 to promote breast cancer metastasis

    Tabariès, S., McNulty, A., Ouellet, V., Annis, M. G., Dessureault, M., Vinette, M., Hachem, Y., Lavoie, B., Omeroglu, A., Simon, H. G., Walsh, L. A., Siker Kimbung, Ingrid Hedenfalk & Siegel, P. M., 2019, I : Genes & Development. 33, 3-4, s. 180-193 14 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2018
  4. Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer

    Severson, T. M., Kim, Y., Joosten, S. E. P., Schuurman, K., Van Der Groep, P., Moelans, C. B., Ter Hoeve, N. D., Manson, Q. F., Martens, J. W., Van Deurzen, C. H. M., Barbe, E., Ingrid Hedenfalk, Bult, P., Smit, V. T. H. B. M., Linn, S. C., Van Diest, P. J., Wessels, L. & Zwart, W., 2018 dec 1, I : Nature Communications. 9, 1, 482.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial

    Siker Kimbung, Markholm, I., Bjöhle, J., Lekberg, T., Wachenfeldt, V. A., Azavedo, E., Saracco, A., Hellström, M., Srinivas Veerla, Paquet, E., Pär Ola Bendahl, Mårten Fernö, Bergh, J., Niklas Loman, Hatschek, T. & Ingrid Hedenfalk, 2018, I : International Journal of Cancer. 142, 3, s. 618-628

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer

    Matikas, A., Lövrot, J., Ramberg, A., Eriksson, M., Lindsten, T., Lekberg, T., Ingrid Hedenfalk, Niklas Loman, Bergh, J., Hatschek, T., Erlandsson, A. & Foukakis, T., 2018, I : OncoImmunology. 7, 9, e1466017.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Ghrelin expression is associated with a favorable outcome in male breast cancer

    Grönberg, M., Nilsson, C., Markholm, I., Ingrid Hedenfalk, Blomqvist, C., Holmberg, L., Tiensuu Janson, E. & Fjällskog, M. L., 2018, I : Scientific Reports. 8, 1, 13586.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. 2017
  9. An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression

    Palazon, A., Tyrakis, P. A., Macias, D., Veliça, P., Rundqvist, H., Fitzpatrick, S., Vojnovic, N., Phan, A. T., Niklas Loman, Ingrid Hedenfalk, Hatschek, T., Lövrot, J., Foukakis, T., Goldrath, A. W., Bergh, J. & Johnson, R. S., 2017 nov 13, I : Cancer Cell. 32, 5, s. 669-683.e5

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: A case control study

    Lawler, K., Papouli, E., Naceur-Lombardelli, C., Mera, A., Ougham, K., Tutt, A., Siker Kimbung, Ingrid Hedenfalk, Zhan, J., Zhang, H., Buus, R., Dowsett, M., Ng, T., Pinder, S. E., Parker, P., Holmberg, L., Gillett, C. E., Grigoriadis, A. & Purushotham, A., 2017 okt 13, I : Breast Cancer Research. 19, 1, 113.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Involvement of chromatin remodeling genes and the Rho GTPases RhoB and CDC42 in ovarian clear cell carcinoma

    Nicolai Skovbjerg Arildsen, Jenny Maria Jönsson, Bartuma, K., Anna Ebbesson, Westbom-Fremer, S., Måsbäck, A., Malander, S., Mef Nilbert & Ingrid A. Hedenfalk, 2017 maj 29, I : Frontiers in Oncology. 7, MAY, s. 1-11 109.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. A case-matched gender comparison transcriptomic screen identifies eIF4E and eIF5 as potential prognostic markers in male breast cancer

    Humphries, M. P., Rajan, S. S., Droop, A., Suleman, C. A. B., Carbone, C., Nilsson, C., Honarpisheh, H., Cserni, G., Dent, J., Fulford, L., Jordan, L. B., Jones, J. L., Kanthan, R., Litwiniuk, M., Di Benedetto, A., Mottolese, M., Provenzano, E., Shousha, S., Stephens, M., Walker, R. A. & 12 andraKulka, J., Ellis, I. O., Jeffery, M., Thygesen, H. H., Cappelletti, V., Daidone, M. G., Ingrid A. Hedenfalk, Fjällskog, M-L., Melisi, D., Stead, L. F., Shaaban, A. M. & Speirs, V., 2017 maj 15, I : Clinical Cancer Research. 23, 10, s. 2575-2583 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2016
  14. Transcriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal A primary breast cancer.

    Siker Kimbung, Johansson, I., Danielsson, A., Srinivas Veerla, Brage, S. E., Frostvik Stolt, M., Skoog, L., Carlsson, L., Einbeigi, Z., Lidbrink, E., Linderholm, B. K., Niklas Loman, Per Malmström, Söderberg, M., Walz, T. M., Fernö, M., Hatschek, T. & Ingrid Hedenfalk, 2016, I : Clinical Cancer Research. 22, 1, s. 146-157

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2015
  16. Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications.

    Siker Kimbung, Kovács, A., Danielsson, A., Pär-Ola Bendahl, Lövgren, K., Stolt, M. F., Tobin, N. P., Lindström, L., Bergh, J., Einbeigi, Z., Mårten Fernö, Hatschek, T. & Ingrid Hedenfalk, 2015, I : Oncotarget. 6, 32, s. 33306-33318

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes.

    Johansson, I., Martin Lauss, Karolina Holm, Johan Staaf, Nilsson, C., Fjällskog, M-L., Markus Ringnér & Ingrid Hedenfalk, 2015, I : Molecular Oncology. 9, 8, s. 1565-1579

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Global transcriptional changes following statin treatment in breast cancer.

    Olöf Bjarnadottir, Siker Kimbung, Johansson, I., Srinivas Veerla, Mats Jönsson, Pär-Ola Bendahl, Grabau, D., Ingrid Hedenfalk & Signe Borgquist, 2015, I : Clinical Cancer Research. 21, 15, s. 3402-3411

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival.

    Jenny-Maria Jönsson, Nicolai Arildsen, Malander, S., Måsbäck, A., Linda Werner Hartman, Mef Nilbert & Ingrid Hedenfalk, 2015, I : Translational Oncology. 8, 5, s. 424-433

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. 2014
  21. 32p * biomarkers and molecular subtypes in primary breast tumors and metastases: associations with liver metastases and outcome.

    Siker Kimbung, Kovács, A., Johansson, I., Danielsson, A., Pär-Ola Bendahl, Einbeigi, Z., Mårten Fernö, Hatschek, T. & Ingrid Hedenfalk, 2014, I : Annals of Oncology. 25 Suppl 1, May, s. i11-i12

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Molecular profiling of male breast cancer - Lost in translation?

    Johansson, I., Killander, F., Linderholm, B. & Ingrid Hedenfalk, 2014, I : International Journal of Biochemistry & Cell Biology. 53, May 16, s. 526-535

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  23. Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes.

    Jenny-Maria Jönsson, Johansson, I., Dominguez, M., Siker Kimbung, Mats Jönsson, Bonde, J. H., Päivi Kannisto, Måsbäck, A., Malander, S., Mef Nilbert & Ingrid Hedenfalk, 2014, I : PLoS ONE. 9, 9, e107643.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer.

    Deb, S., Johansson, I., Byrne, D., Nilsson, C., Investigators, K., Constable, L., Fjällskog, M-L., Dobrovic, A., Ingrid Hedenfalk & Fox, S. B., 2014, I : Modern Pathology. 27, 9, s. 1223-1230

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 2013
  26. Cancerforskning vid Lunds universitet: En rapport avseende forskning inom Regionalt Cancercentrum Syd

    Ingrid Hedenfalk, Graffner, M., Fredrik Åström & Mef Nilbert, 2013, Regionalt Cancercentrum Syd. 9 s.

    Forskningsoutput: Bok/rapportRapport

  27. Effects of Research Funding, Gender and Type of Position on Research Collaboration Networks: A Micro-level Study of Cancer Research at Lund University

    Fredrik Åström, Ingrid Hedenfalk, Graffner, M. & Mef Nilbert, 2013, PROCEEDINGS OF ISSI 2013 Vienna: 14th International Society of Scientometrics and Informetrics Conference. Gorraiz, J., Schiebel, E., Gumpenberger, C., Hörlesberger, M. & Moed, H. (red.). Austrian Institute of Technology GmbH Vienna, s. 677-689

    Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKonferenspaper i proceeding

  28. High proliferation is associated with inferior Outcome in male breast cancer patients

    Nilsson, C., Koliadi, A., Johansson, I., Ahlin, C., Thorstenson, S., Bergkvist, L., Ingrid Hedenfalk & Fjallskog, M-L., 2013, I : Modern Pathology. 26, 1, s. 87-94

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact

    Nilsson, C., Johansson, I., Ahlin, C., Thorstenson, S., Amini, R-M., Holmqvist, M., Bergkvist, L., Ingrid Hedenfalk & Fjallskog, M-L., 2013, I : Acta Oncologica. 52, 1, s. 102-109

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Requirement of Apoptotic Protease-Activating Factor-1 for Bortezomib-Induced Apoptosis but Not for Fas-Mediated Apoptosis in Human Leukemic Cells

    Ottosson-Wadlund, A., Ceder, R., Preta, G., Pokrovskaja, K., Grafstrom, R. C., Heyman, M., Soderhall, S., Grander, D., Ingrid Hedenfalk, Robertson, J. D. & Fadeel, B., 2013, I : Molecular Pharmacology. 83, 1, s. 245-255

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.

    Carina Forsare, Bak, M., Signe Borgquist, Chebil, G., Falck, A-K., Fjällskog, M-L., Grabau, D., Ingrid Hedenfalk, Karin Jirström, Klintman, M., Per Malmström, Olsson, H., Lisa Rydén, Stål, O., Pär-Ola Bendahl & Mårten Fernö, 2013, I : SpringerPlus. 2, 1, 111.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. The Landscape of Candidate Driver Genes Differs between Male and Female Breast Cancer.

    Johansson, I., Markus Ringnér & Ingrid Hedenfalk, 2013, I : PLoS ONE. 8, 10, e78299.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. 2012
  34. Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition.

    Siker Kimbung, Biskup, E., Johansson, I., Kristina Aaltonen, Ottosson-Wadlund, A., Sofia Gruvberger, Cunliffe, H., Fadeel, B., Niklas Loman, Berglund, P. & Ingrid Hedenfalk, 2012, I : Cancer Letters. 319, 2, s. 232-241

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker

    Johansson, I., Nilsson, C., Berglund, P., Martin Lauss, Markus Ringnér, Håkan Olsson, Luts, L., Sim, E., Thorstensson, S., Fjallskog, M-L. & Ingrid Hedenfalk, 2012, I : Breast Cancer Research. 14, 1, R31.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk

    Orr, N., Lemnrau, A., Cooke, R., Fletcher, O., Tomczyk, K., Jones, M., Johnson, N., Lord, C. J., Mitsopoulos, C., Zvelebil, M., McDade, S. S., Buck, G., Blancher, C., Trainer, A. H., James, P. A., Bojesen, S. E., Bokmand, S., Nevanlinna, H., Mattson, J., Friedman, E. & 24 andraLaitman, Y., Palli, D., Masala, G., Zanna, I., Ottini, L., Giannini, G., Hollestelle, A., van den Ouweland, A. M. W., Novakovic, S., Krajc, M., Gago-Dominguez, M., Castelao, J. E., Håkan Olsson, Ingrid Hedenfalk, Easton, D. F., Pharoah, P. D. P., Dunning, A. M., Bishop, D. T., Neuhausen, S. L., Steele, L., Houlston, R. S., Garcia-Closas, M., Ashworth, A. & Swerdlow, A. J., 2012, I : Nature Genetics. 44, 11, s. 1182-1184

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. 2011
  38. High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer

    Johansson, I., Nilsson, C., Berglund, P., Carina Forsare, Göran B Jönsson, Johan Staaf, Markus Ringnér, Nevanlinna, H., Barkardottir, R. B., Åke Borg, Håkan Olsson, Luts, L., Fjallskog, M-L. & Ingrid Hedenfalk, 2011, I : Breast Cancer Research and Treatment. 129, 3, s. 747-760

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden)

    Nilsson, C., Holmqvist, M., Bergkvist, L., Ingrid Hedenfalk, Lambe, M. & Fjallskog, M-L., 2011, I : Acta Oncologica. 50, 7, s. 1083-1088

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. 2010
  41. Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency.

    Rennstam, K., Anita Ringberg, Cunliffe, H. E., Håkan Olsson, Landberg, G. & Ingrid Hedenfalk, 2010, I : Genes, Chromosomes and Cancer. 49, s. 78-90

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.

    Rennstam, K., McMichael, N., Berglund, P., Gabriella Honeth, Cecilia Hegardt, Lisa Rydén, Luts, L., Pär-Ola Bendahl & Ingrid Hedenfalk, 2010, I : Breast Cancer Research and Treatment. 122, s. 315-324

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. 2008
  44. 2007
  45. 2006
  46. cDNA Microarrays in Cancer Research.

    Brown, KM., Ingrid Hedenfalk & Trent, JM., 2006, Cancer: Principles and Practise of Oncology. DeVita, VT., Hellman, S. & Rosenberg, SA. (red.). Lippincott Williams & Wilkins, s. 13-25

    Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKapitel samlingsverk

  47. Gene Expression Profiling Can Distinguish Tumor Subclasses of Breast Carcinomas.

    Ingrid Hedenfalk, 2006, Gene Expression Profiling by Microarrays – Clinical Implications.. Hofmann, W. K. (red.). Cambridge University Press, s. 132

    Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKapitel samlingsverk

  48. Microarrays in breast cancer research and clinical practice - the future lies ahead

    Sofia Gruvberger, Cunliffe, H. E., Carr, K. M. & Ingrid Hedenfalk, 2006, I : Endocrine-Related Cancer. 13, 4, s. 1017-1031

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  49. 2005
  50. Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers.

    Berglund, P., Stighall, M., Karin Jirström, Signe Borgquist, Anita Sjölander, Ingrid Hedenfalk & Landberg, G., 2005, I : Cancer Research. 65, 21, s. 9727-9734

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. Microarray-based Analyses of Hypoxia-induced Transcriptional Changes in Breast Cancer Cell Lines

    Ingrid Hedenfalk, Glarner, N., Kronblad, Å., Srinivas Veerla, Markus Ringnér & Landberg, G., 2005, I : Cancer Genomics & Proteomics. 2, 2, s. 83-95

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 Nästa